146 related articles for article (PubMed ID: 23877105)
1. More relevant prediction for in vivo drug interaction of candesartan cilexetil on hepatic bile acid transporter BSEP using sandwich-cultured hepatocytes.
Fukuda H; Nakanishi T; Tamai I
Drug Metab Pharmacokinet; 2014; 29(1):94-6. PubMed ID: 23877105
[TBL] [Abstract][Full Text] [Related]
2. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
3. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
[TBL] [Abstract][Full Text] [Related]
4. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
Kruglov EA; Gautam S; Guerra MT; Nathanson MH
Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
[TBL] [Abstract][Full Text] [Related]
6. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.
Garzel B; Yang H; Zhang L; Huang SM; Polli JE; Wang H
Drug Metab Dispos; 2014 Mar; 42(3):318-22. PubMed ID: 24335466
[TBL] [Abstract][Full Text] [Related]
7. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
[TBL] [Abstract][Full Text] [Related]
8. Bile salt export pump (BSEP/ABCB11): trafficking and sorting disturbances.
Hayashi H; Sugiyama Y
Curr Mol Pharmacol; 2013 Jul; 6(2):95-103. PubMed ID: 23876151
[TBL] [Abstract][Full Text] [Related]
9. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase.
Kubitz R; Sütfels G; Kühlkamp T; Kölling R; Häussinger D
Gastroenterology; 2004 Feb; 126(2):541-53. PubMed ID: 14762791
[TBL] [Abstract][Full Text] [Related]
10. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
[TBL] [Abstract][Full Text] [Related]
12. Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat.
Crocenzi FA; Mottino AD; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Milkiewicz P; Vore M; Coleman R; Roma MG
Gut; 2003 Aug; 52(8):1170-7. PubMed ID: 12865277
[TBL] [Abstract][Full Text] [Related]
13. Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
Kis E; Ioja E; Nagy T; Szente L; Herédi-Szabó K; Krajcsi P
Drug Metab Dispos; 2009 Sep; 37(9):1878-86. PubMed ID: 19520776
[TBL] [Abstract][Full Text] [Related]
14. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
[TBL] [Abstract][Full Text] [Related]
15. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
17. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
18. Function and Expression of Bile Salt Export Pump in Suspension Human Hepatocytes.
Chothe PP; Pemberton R; Hariparsad N
Drug Metab Dispos; 2021 Apr; 49(4):314-321. PubMed ID: 33472814
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
[TBL] [Abstract][Full Text] [Related]
20. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
Ali I; Khalid S; Stieger B; Brouwer KLR
Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]